This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzsimmons, C. M.
Right arrow Articles by Dunne, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzsimmons, C. M.
Right arrow Articles by Dunne, D. W.

 Previous Article  |  Next Article 

Infection and Immunity, July 2004, p. 4023-4030, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4023-4030.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Chemotherapy for Schistosomiasis in Ugandan Fishermen: Treatment Can Cause a Rapid Increase in Interleukin-5 Levels in Plasma but Decreased Levels of Eosinophilia and Worm-Specific Immunoglobulin E

Colin M. Fitzsimmons,1* Sarah Joseph,1 Frances M. Jones,1 Claus M. Reimert,2 Karl F. Hoffmann,1 Francis Kazibwe,3 Gachuhi Kimani,4 Joseph K. Mwatha,4 John H. Ouma,4 Edridah M. Tukahebwa,3 Henry. C. Kariuki,5 Birgitte J. Vennervald,2 Narcis B. Kabatereine,3 and David W. Dunne1

Department of Pathology, University of Cambridge, Cambridge, United Kingdom,1 Danish Bilharziasis Laboratory, Charlottenlund, Denmark,2 Vector Control Division, Ugandan Ministry of Health, Kampala, Uganda,3 Kenya Medical Research Institute,4 Division of Vector Borne Diseases, Kenyan Ministry of Health, Nairobi, Kenya5

Received 3 November 2003/ Returned for modification 5 January 2004/ Accepted 2 April 2004

Chemotherapy for blood-dwelling schistosomes kills the worms and exposes parasite antigen to the circulation. In many people from areas of endemicity, this treatment increases parasite-specific immunoglobulin E (IgE) and other Th2 responses in the months following therapy, responses that have been associated with subsequent resistance to reinfection. Here we investigate much earlier changes in immune reactions after praziquantel therapy in Schistosoma mansoni-infected fishermen working in an area of high transmission in Uganda. The subjects gave blood before treatment and at 1 and 21 days posttreatment. Blood cultures were incubated with schistosome soluble worm antigen (SWA) or soluble egg antigen (SEA). Interleukin-4 (IL-4), IL-5, IL-10, IL-13, gamma interferon, and transforming growth factor ß levels were measured in the cultures and in plasma. A marked transient increase in plasma IL-5 levels was observed in 75% of the subjects (n = 48) by 1 day posttreatment. This response was dependent on pretreatment intensity of infection and was accompanied by a transient decrease in eosinophil numbers. One day posttreatment, blood cultures from the 16 subjects with the greatest increase in plasma IL-5 level (>100 pg/ml) displayed reduced IL-5, IL-13, and IL-10 responses to SWA, and in contrast to the rest of the cohort, these high-IL-5 subjects displayed reduced levels of SWA-specific IgE in plasma 21 days posttreatment. Twenty months after treatment, the intensity of reinfection was positively correlated with the increase in plasma IL-5 level seen 1 day posttreatment. These studies describe the heterogeneity in early immune reactions to treatment, identifying subgroups who have different patterns of reaction and who may have different capacities to mount the responses that have been associated with resistance to reinfection.

* Corresponding author. Mailing address: Department of Pathology, University of Cambridge, Cambridge, United Kingdom. Phone: 44-1223-333332. Fax: 44-1223-333741. E-mail: cmf1000{at}cam.ac.uk.

Editor: J. F. Urban, Jr.

Infection and Immunity, July 2004, p. 4023-4030, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4023-4030.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Watanabe, K., Mwinzi, P. N. M., Black, C. L., Muok, E. M. O., Karanja, D. M. S., Secor, W. E., Colley, D. G. (2007). T Regulatory Cell Levels Decrease in People Infected With Schistosoma mansoni on Effective Treatment. Am J Trop Med Hyg 77: 676-682 [Abstract] [Full Text]  
  • SHEN, C., CHOI, M.-H., BAE, Y. M., YU, G., WANG, S., HONG, S.-T. (2007). A CASE OF ANAPHYLACTIC REACTION TO PRAZIQUANTEL TREATMENT. Am J Trop Med Hyg 76: 603-605 [Abstract] [Full Text]  
  • Booth, M., Shaw, M. A., Carpenter, D., Joseph, S., Kabatereine, N. B., Kariuki, H. C., Mwatha, J. K., Jones, F. M., Vennervald, B. J., Ouma, J. H., Dunne, D. W. (2006). Carriage of DRB1*13 Is Associated with Increased Posttreatment IgE Levels against Schistosoma mansoni Antigens and Lower Long-Term Reinfection Levels.. J. Immunol. 176: 7112-7118 [Abstract] [Full Text]  
  • Reimert, C. M., Fitzsimmons, C. M., Joseph, S., Mwatha, J. K., Jones, F. M., Kimani, G., Hoffmann, K. F., Booth, M., Kabatereine, N. B., Dunne, D. W., Vennervald, B. J. (2006). Eosinophil Activity in Schistosoma mansoni Infections In Vivo and In Vitro in Relation to Plasma Cytokine Profile Pre- and Posttreatment with Praziquantel.. CVI 13: 584-593 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»